These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34587392)

  • 21. Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
    Rubin EJ; Baden LR; Lee TH; Morrissey S
    N Engl J Med; 2021 Jan; 384(1):e13. PubMed ID: 33406335
    [No Abstract]   [Full Text] [Related]  

  • 22. Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    Abbasi J
    JAMA; 2021 Aug; 326(6):473. PubMed ID: 34374737
    [No Abstract]   [Full Text] [Related]  

  • 23. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
    Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
    N Engl J Med; 2021 Jan; 384(2):e14. PubMed ID: 33497556
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccines against COVID-19.
    Locht C
    Anaesth Crit Care Pain Med; 2020 Dec; 39(6):703-705. PubMed ID: 33096260
    [No Abstract]   [Full Text] [Related]  

  • 25. Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    Rubin EJ; Baden LR; Walensky RP; Morrissey S
    N Engl J Med; 2021 Apr; 384(16):e73. PubMed ID: 33882211
    [No Abstract]   [Full Text] [Related]  

  • 26. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 27. Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
    Rubin EJ; Baden LR; Northam RS; Morrissey S
    N Engl J Med; 2021 Feb; 384(5):e25. PubMed ID: 33534981
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    Abu-Raddad LJ; Chemaitelly H; Butt AA;
    N Engl J Med; 2021 Jul; 385(2):187-189. PubMed ID: 33951357
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Scharf RE; Alberio L
    Hamostaseologie; 2021 Jun; 41(3):179-182. PubMed ID: 34192777
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.
    Capone S; Raggioli A; Gentile M; Battella S; Lahm A; Sommella A; Contino AM; Urbanowicz RA; Scala R; Barra F; Leuzzi A; Lilli E; Miselli G; Noto A; Ferraiuolo M; Talotta F; Tsoleridis T; Castilletti C; Matusali G; Colavita F; Lapa D; Meschi S; Capobianchi M; Soriani M; Folgori A; Ball JK; Colloca S; Vitelli A
    Mol Ther; 2021 Aug; 29(8):2412-2423. PubMed ID: 33895322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccines: the importance of transparency and fact-based education.
    Cohen AF; van Gerven J; Burgos JG; de Boer A; Foucher RAM; Flore H; Teitelbaum Z; van Eden W; Webb A; Cremers S
    Br J Clin Pharmacol; 2020 Nov; 86(11):2107-2110. PubMed ID: 33464636
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
    Peter J
    S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    Del Rio C; Malani PN; Omer SB
    JAMA; 2021 Sep; 326(11):1001-1002. PubMed ID: 34406361
    [No Abstract]   [Full Text] [Related]  

  • 36. SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519816
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
    Sharif N; Alzahrani KJ; Ahmed SN; Dey SK
    Front Immunol; 2021; 12():714170. PubMed ID: 34707602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report.
    Golding B; Lee Y; Golding H; Khurana S
    Ann Rheum Dis; 2021 Oct; 80(10):1359-1361. PubMed ID: 34272252
    [No Abstract]   [Full Text] [Related]  

  • 39. Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: decline in antibodies 12 weeks after two doses.
    Zee JST; Lai KTW; Ho MKS; Leung ACP; Fung LH; Luk WP; Kwok LF; Kee KM; Chan QWL; Tang SF; Ma ESK; Lee KH; Lau CC; Yung RWH
    Hong Kong Med J; 2021 Oct; 27(5):380-383. PubMed ID: 34657837
    [No Abstract]   [Full Text] [Related]  

  • 40. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
    Liu Y; Liu J; Xia H; Zhang X; Zou J; Fontes-Garfias CR; Weaver SC; Swanson KA; Cai H; Sarkar R; Chen W; Cutler M; Cooper D; Muik A; Sahin U; Jansen KU; Xie X; Dormitzer PR; Shi PY
    N Engl J Med; 2021 Jul; 385(5):472-474. PubMed ID: 33979486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.